The oncogenic MET mutation Y1235D, which is described for different cancer types such as hereditary papillary renal carcinoma and advanced head and neck squamous cell carcinoma, leads to constitutive kinase activation presumably by destabilizing the autoinhibited KD conformation (10, 12, 13, 14). Here, MET is linked to cancer.